InflaRx Reports Full Year 2019 Financial & Operating Results

Secarna Pharmaceuticals enters into cooperation with Guangzhou’s Sun Yat-sen University to develop a treatment for SARS-CoV-2 viral infections

MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Protocol for the next Stage of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

CEVEC Announces the Launch of the ELEVECTA® Platform – the Stable Producer Cell Line Technology for AAV Gene Therapy Vectors

Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement

Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program

4basebio AG Reports positive Financial Results for Fiscal Year 2019 – Financial Guidance Met

LEUKOCARE AG: ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2020

ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine